Form 4 Tracker
Korsana Biosciences, Inc.
KRSA

4 insider filings · Latest: Sep 9, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Sep 23, 2026Sep 23 8:50 PMERROL B DE SOUZA
Proposed Sale
4,903$34.99$171.6K—

View →

Sep 22, 2026Sep 22 8:56 PMERROL B DE SOUZA
Proposed Sale
100$34.99$3.5K—

View →

Sep 18, 2026Sep 18 8:49 PMERROL B DE SOUZA
Proposed Sale
2,139$34.99$74.8K—

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Sep 9, 2026Sep 10 9:45 PMMichelle Patricia PerniceDirector
Grant/Award
48,445$26.2048,445(D)

View →

Sep 9, 2026Sep 10 9:45 PMNimish P ShahDirector
Grant/Award
48,445$26.2048,445(D)

View →

Sep 9, 2026Sep 10 9:44 PMFairmount Funds Management LLCDirector, 10% Owner
Grant/Award
48,445$26.2048,445(I)

View →

Sep 9, 2026Sep 10 9:43 PMAndrew GottesdienerDirector
Grant/Award
48,445$26.2048,445(D)

View →

Aug 14, 2026Aug 18 9:27 PMRhonda M. ChickoChief Financial Officer
Option Exercise
25,000$2.360(D)

View →

Aug 14, 2026Aug 18 9:21 PMRegina Margaret GraulDirector, President and Chief Executive Officer
Option Exercise
55,849$3.300(D)

View →

Jul 16, 2026Jul 20 9:04 PMHecht Peter MDirector, 10% Owner
Conversion
351,037—0(D)

View →